亚临床甲状腺功能减退症与动脉粥样硬化的相关性

doi:10.3969/j.issn.1004-583X.2016.04.010

临床荟萃 ›› 2016, Vol. 31 ›› Issue (4): 386-388.doi: 10.3969/j.issn.1004-583X.2016.04.010

亚临床甲状腺功能减退症与动脉粥样硬化的相关性

郭妮^a, 甘振钊^b, 苏庆建^a

广西医科大学第三附属医院 a.内分泌科; b.心血管内科2病区,广西南宁 530031

收稿日期:2015-12-23 出版日期:2016-04-05 发布日期:2016-04-18
通讯作者: 甘振钊,Email:nngn98@163.com
基金资助:
广西南宁市科学研究与技术开发计划项目资助(NO.2007011410C)

Relationship analysis between subclinical hypothyroidism and atherosclerosis

Guo Ni^a, Gan Zhenzhao^b, Su Jianqing^a

a. Department of Endocrineology; b. Department of Cardiology, the Third Affiliated Hospital of Guangxi Medical University, Nanning 530031, China

Received:2015-12-23 Online:2016-04-05 Published:2016-04-18
Contact: Gan Zhenzhao,Email:nngn98@163.com

摘要/Abstract

摘要： 目的探讨亚临床型甲状腺功能减退症(subclinicalhypothyroidism, SCH)与动脉粥样硬化之间的关系。方法选取SCH患者80例,同时选取甲状腺功能正常的健康志愿者80例作为对照组,比较两组甲状腺功能相关指标:促甲状腺激素(TSH) 、血清游离三碘甲腺原氨酸(FT3)、血清游离甲状腺素(FT4);动脉粥样硬化相关指标:高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)、甘油三酯(TG)、血栓素B2(TXB2)、C反应蛋白(CRP)、颈动脉中层厚度(cIMT)的变化,并对各指标的相关性进行研究。结果 SCH组TSH、LDL-C、TC、TXB2及cIMT明显高于对照组(P<0.01);Pearson相关分析显示,TSH与TC、LDL-C、TXB2、cIMT呈正相关;多元线性回归分析结果显示,cIMT与LDL-C、TSH独立相关。结论 SCH患者血清中高水平TSH与动脉粥样硬化的发生存在一定的相关性。

关键词: 甲状腺功能减退症, 促甲状腺素, 动脉粥样硬化

Abstract: Objective To explore the relationship between subclinical hypothyroidism (SCH) and atherosclerosis.Methods Eighty patients with SCH and eighty volunteers with euthyroidism were contained in the study as SCH group and control group, respectively. All indicators were examined as follows:thyroid function-related indicators such as TSH, FT3 and FT4; atherosclerosis-related indicator such as HDL-C,LDL-C,TC,TG,TXB2,CRP and cIMT. Correlation study was performed between indicators.Results The levels of TSH, LDL-C, TC and TXB2 in SCH group were significantly higher than those of control group(P<0.01). Pearson correlation analysis showed that TSH level was positively correlated with TC, LDL-C, TXB2 and cIMT level. Multivariate regression analysis showed that cIMT was independently correlated with LDL-C and TSH.Conclusion There appeared some correlation bteween the high level of TSH in patients with SCH and the development of atherosclerosis

Key words: hypothyroidism, thyrotropin, atherosclerosis

中图分类号:

R581.2

引用本文

郭妮, 甘振钊, 苏庆建. 亚临床甲状腺功能减退症与动脉粥样硬化的相关性[J]. 临床荟萃, 2016, 31(4): 386-388.

Guo Ni, Gan Zhenzhao, Su Jianqing. Relationship analysis between subclinical hypothyroidism and atherosclerosis[J]. Clinical Focus, 2016, 31(4): 386-388.

使用本文

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.04.010

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I4/386

参考文献

[1] McQuade C, Skugor M, Brennan DM et al: Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study[J]. Thyroid, 2016, Feb 3 [Epub ahead of print].
[2] Pearce EN.In people with subclinical hypothyroidism, TSH level >10 mIU/l may predict increased risk of coronaryheart disease and related mortality[J]. Evid Based Med, 2011, 16(1):31-32.
[3] Gao CX, Yang B, Guo Q,et al. High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism[J]. Horm Metab Res, 2015,47(3):220-224.
[4] 马丽娜,李辉,张魄. 亚临床甲状腺功能减退与心血管疾病的研究现状[J]. 临床荟萃,2013,28(8):941-942.
[5] Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management[J]. JAMA,2004, 291(2):228-238.
[6] 刘晓梅.吴炜杰,张芳. 甲状腺功能减低患者血中脂蛋白及载脂蛋白水平变化的分析[J]. 临床荟萃,2004,19(4):217.
[7] Kilic ID, Tanriverdi H, Fenkci S,et al. Noninvasive indicators of atherosclerosis in subclinical hypothyroidism[J]. Indian J Endocrinol Metab,2013,17(2):271-275.
[8] Posadas-Romero C, Jorge-Galarza E, Posadas-Sanchez R et al. Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis[J]. Eur J Endocrinol,2014,171(3):319-325.
[9] Zhang X, Shao S, Geng H, et al. Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study[J]. J Clin Endocrinol Metab, 2014,99(5):E766-774.
[10] 李博一,文磊,罗平,等. 亚临床甲状腺功能减退症与动脉粥样硬化的关系分析[J]. 医学理论与实践,2012, 25(9):1022-1023.
[11] Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study[J]. J Clin Endocrinol Metab,2004, 89(5):2099-2106.
[12] Jorde R, Joakimsen O, Stensland E, et al. Lack of significant association between intima-media thickness in the carotid artery and serum TSH level. The Troms Study[J].Thyroid,2008,18(1):21-25.
[13] Kooijman S, Meurs I, van der Stoep M,et al. Hematopoietic alpha7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis[J]. J Thromb Haemost, 2015,13(1):126-135.
[14] Gremmel T, Kopp CW, Seidinger D,et al. Impact of diabetes on platelet activation in different manifestations of atherosclerosis[J]. Swiss Med Wkly, 2013,143:w13800.
[15] Saleh HM, Attia EA, Onsy AM,et al. Platelet activation: a link between psoriasis per se and subclinical atherosclerosis--a case-control study[J]. Br J Dermatol, 2013,169(1):68-75.
[16] Shen L, Matsunami Y, Quan N et al. In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice [J]. Isr Med Assoc J, 2011,13(5):278-283.
[17] 杜慧琪,秦勤,李杨.血浆同型半胱氨酸、超敏C反应蛋白与中青年急性冠状动脉综合征的相关性[J]. 临床荟萃,2016,31(2):194-197.
[18] 毛艳阳,王军强,王晨霞,等. 丹参多酚酸盐对不稳定型心绞痛患者血清超敏C反应蛋白及肿瘤坏死因子α水平的影响[J]. 临床荟萃,2016,31(2):191-193.
[19] Piechota W, Piechota W. Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease[J]. Pol Merkur Lekarski,2005,18(107):511-515.
[20] Egorova MO. Increased serum level of the acute inflammation phase parameter CRP and the high level of low density lipoprotein cholesterol--factors of increased risk of development of atherosclerosis and its complications (a literature review) [J]. Klin Lab Diagn,2002,(6):3-6.

相关文章 15

[1] 徐阳, 薛凌. H型高血压合并2型糖尿病患者轻度认知功能障碍的影响因素[J]. 临床荟萃, 2023, 38(10): 887-892.

[2] 迟秀娥, 张倩, 李文东, 王元松, 康静蕊. 误诊为癫痫的假性甲状旁腺功能减退症Ia型1例并文献复习[J]. 临床荟萃, 2022, 37(9): 827-830.

[3] 张磊, 娄海东, 智昱, 亓树莹. PCSK9抑制剂对动脉粥样硬化性心血管疾病有效性及安全性的meta分析[J]. 临床荟萃, 2022, 37(12): 1074-1080.

[4] 左秀秀, 侯天华, 王宏祥. 亚临床甲状腺功能减退与慢性收缩性心力衰竭患者预后关系的meta分析[J]. 临床荟萃, 2022, 37(10): 905-911.

[5] 贺容容, 李锦霞, 任俊豪, 孙辉. 单核细胞与高密度脂蛋白胆固醇比值在动脉粥样硬化性疾病中的研究进展[J]. 临床荟萃, 2022, 37(10): 950-952.

[6] 文洁. 血浆致动脉粥样硬化指数与非酒精性脂肪性肝病的相关性[J]. 临床荟萃, 2022, 37(1): 35-38.

[7] 才可新, 郭宏举, 于淑霞, 常李荣. 左旋甲状腺素对妊娠期亚临床甲状腺功能减退症妊娠结局影响的荟萃分析[J]. 临床荟萃, 2021, 36(9): 773-777.

[8] 刘宇博, 冯平勇, 杨海骁, 孙婕, 张天资. 高分辨磁共振血管壁成像在颅内动脉粥样硬化性缺血性卒中的研究进展[J]. 临床荟萃, 2021, 36(12): 1148-1152.

[9] 王超, 万多, 李卅立, 王曦. 颈动脉多普勒超声对慢性肾病患者动脉粥样硬化程度及血流动力学的评估价值[J]. 临床荟萃, 2021, 36(11): 1009-1012.

[10] 陈隽, 周一薇, 李秀娟. 症状性下肢动脉疾病抗栓治疗分析[J]. 临床荟萃, 2021, 36(10): 937-941.

[11] 尚启航, 陈华茜. 维持性血液透析患者嗜酸性粒细胞水平与颈动脉粥样硬化的关系[J]. 临床荟萃, 2021, 36(1): 44-48.

[12] 王红梅，张婷，陈静炯，邓江山，徐周伟，付剑亮，赵玉武. 低T3水平与大动脉粥样硬化型脑梗死患者短期预后的关系[J]. 临床荟萃, 2020, 35(6): 517-520.

[13] 严巧巧1, 狄亚珍2. 幼年特发性关节炎患儿易早发动脉粥样硬化[J]. 临床荟萃, 2020, 35(1): 92-96.

[14] 严雯，孙波，任建功. 脑梗死患者颈动脉粥样硬化斑块与血清YKL-40关系的meta分析[J]. 临床荟萃, 2018, 33(8): 700-704.

[15] 都建苹1，安振梅2a，唐向东2b. 阻塞性睡眠呼吸暂停低通气综合征对甲状腺功能的影响[J]. 临床荟萃, 2018, 33(2): 136-139.

编辑推荐

Metrics

阅读次数

全文

摘要

本文评价

摘要

参考文献

相关文章

编辑推荐

Metrics

本文评价

回顶部

亚临床甲状腺功能减退症与动脉粥样硬化的相关性

Relationship analysis between subclinical hypothyroidism and atherosclerosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐阳, 薛凌. H型高血压合并2型糖尿病患者轻度认知功能障碍的影响因素[J]. 临床荟萃, 2023, 38(10): 887-892.
[2]	迟秀娥, 张倩, 李文东, 王元松, 康静蕊. 误诊为癫痫的假性甲状旁腺功能减退症Ia型1例并文献复习[J]. 临床荟萃, 2022, 37(9): 827-830.
[3]	张磊, 娄海东, 智昱, 亓树莹. PCSK9抑制剂对动脉粥样硬化性心血管疾病有效性及安全性的meta分析[J]. 临床荟萃, 2022, 37(12): 1074-1080.
[4]	左秀秀, 侯天华, 王宏祥. 亚临床甲状腺功能减退与慢性收缩性心力衰竭患者预后关系的meta分析[J]. 临床荟萃, 2022, 37(10): 905-911.
[5]	贺容容, 李锦霞, 任俊豪, 孙辉. 单核细胞与高密度脂蛋白胆固醇比值在动脉粥样硬化性疾病中的研究进展[J]. 临床荟萃, 2022, 37(10): 950-952.
[6]	文洁. 血浆致动脉粥样硬化指数与非酒精性脂肪性肝病的相关性[J]. 临床荟萃, 2022, 37(1): 35-38.
[7]	才可新, 郭宏举, 于淑霞, 常李荣. 左旋甲状腺素对妊娠期亚临床甲状腺功能减退症妊娠结局影响的荟萃分析[J]. 临床荟萃, 2021, 36(9): 773-777.
[8]	刘宇博, 冯平勇, 杨海骁, 孙婕, 张天资. 高分辨磁共振血管壁成像在颅内动脉粥样硬化性缺血性卒中的研究进展[J]. 临床荟萃, 2021, 36(12): 1148-1152.
[9]	王超, 万多, 李卅立, 王曦. 颈动脉多普勒超声对慢性肾病患者动脉粥样硬化程度及血流动力学的评估价值[J]. 临床荟萃, 2021, 36(11): 1009-1012.
[10]	陈隽, 周一薇, 李秀娟. 症状性下肢动脉疾病抗栓治疗分析[J]. 临床荟萃, 2021, 36(10): 937-941.
[11]	尚启航, 陈华茜. 维持性血液透析患者嗜酸性粒细胞水平与颈动脉粥样硬化的关系[J]. 临床荟萃, 2021, 36(1): 44-48.
[12]	王红梅，张婷，陈静炯，邓江山，徐周伟，付剑亮，赵玉武. 低T3水平与大动脉粥样硬化型脑梗死患者短期预后的关系[J]. 临床荟萃, 2020, 35(6): 517-520.
[13]	严巧巧1, 狄亚珍2. 幼年特发性关节炎患儿易早发动脉粥样硬化[J]. 临床荟萃, 2020, 35(1): 92-96.
[14]	严雯，孙波，任建功. 脑梗死患者颈动脉粥样硬化斑块与血清YKL-40关系的meta分析[J]. 临床荟萃, 2018, 33(8): 700-704.
[15]	都建苹1，安振梅2a，唐向东2b. 阻塞性睡眠呼吸暂停低通气综合征对甲状腺功能的影响[J]. 临床荟萃, 2018, 33(2): 136-139.